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Fungal pathogens can be recognized by the immune system via their b-glucan, a potent proinflammatory molecule
that is present at high levels but is predominantly buried beneath a mannoprotein coat and invisible to the host. To
investigate the nature and significance of ‘‘masking’’ this molecule, we characterized the mechanism of masking and
consequences of unmasking for immune recognition. We found that the underlying b-glucan in the cell wall of Candida
albicans is unmasked by subinhibitory doses of the antifungal drug caspofungin, causing the exposed fungi to elicit a
stronger immune response. Using a library of bakers’ yeast (Saccharomyces cerevisiae) mutants, we uncovered a
conserved genetic network that is required for concealing b-glucan from the immune system and limiting the host
response. Perturbation of parts of this network in the pathogen C. albicans caused unmasking of its b-glucan, leading
to increased b-glucan receptor-dependent elicitation of key proinflammatory cytokines from primary mouse
macrophages. By creating an anti-inflammatory barrier to mask b-glucan, opportunistic fungi may promote
commensal colonization and have an increased propensity for causing disease. Targeting the widely conserved gene
network required for creating and maintaining this barrier may lead to novel broad-spectrum antimycotics.
Citation: Wheeler RT, Fink GR (2006) A drug-sensitive genetic network masks fungi from the immune system. PLoS Pathog 2(4): e35. DOI: 10.1371/journal.ppat.0020035
Introduction
The innate immune system recognizes microbes based on
their pathogen-associated molecular patterns (PAMPs), which
provoke pathogen-speciﬁc responses tailored to meet the
challenge [1]. This ensures that parasites, viruses, bacteria,
and fungi are each attacked appropriately. Fungi are
opportunistic pathogens responsible for occasionally severe
disease in individuals with systemic disease [2,3]. Candida
albicans, clinically the leading fungal pathogen, is recognized
predominantly by two PAMPs (b-glucan and mannan), which
account by weight for over 90% of its cell wall [4,5]. The cell
wall of these and other fungi is tiered, with an outer layer of
mannoproteins covalently linked to an inner core of b-glucan
(Figure 1A).
The inner b-glucan layer is an essential cell wall component
targeted by fungicidal antibodies, immune receptors, and the
echinocandin class of antifungal drugs. Recent work has
shown that anti-b-glucan antibodies can directly kill fungi
and assist in the clearance of fungal infection [6]. The b-
glucan receptor Dectin-1 also recognizes fungi and mediates
the innate immune system’s proinﬂammatory response [7].
The importance of this layer is also underscored by the
effectiveness of the echinocandins, which bind and inhibit b-
glucan synthase to cause cell lysis [8].
The importance of this inner b-glucan layer for immune
targeting belies an interesting paradox. Although it accounts
for a major fraction of the cell wall, b-glucan is buried
underneath a thin but dense mannan coat (Figure 1A) [9].
This tiered arrangement of the cell surface raises several
important issues: How do the cells of the immune system
recognize b-glucan if it is coated with mannoproteins?
Furthermore, what fungal genes function to ‘‘mask’’ the b-
glucan from the immune system?
In this study, we report the mechanisms and consequences
of b-glucan masking and unmasking in the fungal-immune
interaction. Growth of C. albicans in the presence of
subinhibitory concentrations of the antifungal drug caspo-
fungin exposes the normally masked b-glucan. We also deﬁne
a conserved genetic network responsible for b-glucan mask-
ing in the genetically tractable, nonpathogenic model fungus
Saccharomyces cerevisiae and conﬁrm its requirement in the
pathogen C. albicans. Exposure of b-glucan by drug treatment
or mutation alters the way the fungi are recognized by
immune cells, causing a b-glucan-dependent increase in the
elicitation of tumor necrosis factor alpha (TNFa)f r o m
macrophages. For C. albicans, this unmasking transforms the
fungi into cells that elicit a strong proinﬂammatory response.
Thus, fungi camouﬂage the majority of their b-glucan from
innate immune cells to lower the proinﬂammatory response
to infection.
Results
The Cell Wall b-Glucan Is Masked in S. cerevisiae and
C. albicans
Despite the high bulk levels of b-glucan throughout the
fungal cell wall, C. albicans and laboratory strains of S. cerevisiae
have little exposed b-glucan (Figure 1B–1D). The accessibility
of b-glucan was measured in live fungal cells using three
different reagents that colocalize: a monoclonal antibody
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carbohydrate recognition domain (Dectin-CRD), and Dectin-
CRD preincubated with ﬂuorescently labeled antiepitope
antibody (CRD-Myc; see Materials and Methods). Each of
these three reagents interacts only weakly with intact cells of
both C. albicans and laboratory strains of S. cerevisiae.
Consistent with the biological relevance of masking of this
proinﬂammatory molecule, intact cells of C. albicans and S.
cerevisiae elicit little immune response when presented to
macrophages.
In agreement with previous reports [11], the primary areas
of glucan-inhibitable binding of Dectin-1 and the anti-b-
glucan antibody are the sites of previous cell wall remodeling
(i.e., bud scars, birth scars, and bud necks). Wild-type fungal
cells have abundant b-glucan in their cell walls but present
little b-glucan to the immune system, and this trace amount is
restricted to the sites of cell division. As most of the cells in a
culture are newly generated, they have completed only one
division and would be less efﬁciently recognized by immune
molecules. Thus, it seems that fungi have developed con-
served pathways to conceal the potent proinﬂammatory
molecule b-glucan from the immune system.
Fungal b-Glucan Is Exposed by Subinhibitory Doses of
Caspofungin
We reasoned that antifungal drugs that speciﬁcally target
cell-wall biosynthetic pathways would disrupt the intricate
architecture of the cell wall and heighten b-glucan exposure,
‘‘unmasking’’ the cells through uncoating or cell wall
disorganization. To examine this possibility, we grew wild-
type C. albicans overnight in the presence of subinhibitory
doses of caspofungin (CF), a potent echinocandin that is a
recent addition to the antifungal arsenal [8]. Remarkably, at
CF concentrations that permit normal growth rates the drug
caused exposure of b-glucan on the C. albicans cell surface
(Figure 2A and 2B). At these drug concentrations, the cells
had 103–303 greater reactivity with the anti-b-glucan anti-
body. It is important to note that the fungi grow at these drug
concentrations without loss of viability (Figure 2C), suggest-
ing that the increased b-glucan exposure is not due to
generalized cell death. We also examined the effect of CF on
cells grown in RPMI 1640, a culture medium that causes
strong hyphal growth and b-glucan masking [11]. Subinhibi-
tory doses of CF caused a dramatic increase in the exposure
of b-glucan on hyphae grown in this media (Figure 2D). These
cells also did not show increased cell death, as measured by
microscopic examination.
Caspofungin inhibits the synthesis of b-glucan, which leads
to lower bulk levels of b-glucan in the cell [8]; however, the
inhibition of b-glucan biosynthesis also upsets the equili-
brium required to maintain the normal tiered cell wall
architecture [12]. This perturbation of the cell wall remodel-
ing machinery can cause more exposure of b-glucan even in
the presence of lower bulk levels of b-glucan. This fact also
suggests that fungi have evolved a mechanism for masking b-
glucan that is compromised by the drug.
Caspofungin-Treated Cells Hyperelicit TNFa
Since b-glucan is the primary proinﬂammatory molecule
on the fungal surface, we tested whether yeast unmasked by
CF elicit larger proinﬂammatory responses from macro-
phages. This test requires inactivation of the fungi to prevent
them from killing the macrophages before the end of the
experiment. Previously used methods of inactivation (includ-
ing heat, formaldehyde, and ethanol) artiﬁcially increase b-
glucan exposure and lead to high levels of TNFa elicitation
(Figure S1). We discovered that ultraviolet light (UV)-
irradiated cells did not kill macrophages, retained an intact
cell wall architecture, and elicited only low levels of TNFa
(Figure S1). Therefore, we used UV-inactivated fungi for all
subsequent experiments.
To test whether unmasked, CF-treated yeast elicit a greater
proinﬂammatory response, we exposed CF-treated or
-untreated (exposed or masked, respectively) C. albicans to
primary bone marrow-derived macrophages (BMDMs) and
assayed elicitation of the key proinﬂammatory cytokine
TNFa. The CF-treated C. albicans elicited 3- to 4-fold higher
levels of the key proinﬂammatory cytokine TNFa (Figure 2E)
than did untreated C. albicans, which elicited undetectable
levels of TNFa in this assay. Thus, subinhibitory doses of CF
cause the pathogen to elicit a marked proinﬂammatory
response.
An Interconnected Genetic Network Is Required for b-
Glucan Masking
To identify the system used by fungi to mask their b-glucan
from the immune system, we screened a genome-wide library
of knockout mutants in S. cerevisiae for increased b-glucan
exposure. Because subinhibitory levels of CF are able to cause
increased b-glucan exposure and altered recognition of the
fungi without killing the fungi, we reasoned that this library
of nonessential gene knockouts should identify genes that
speciﬁcally perturb the genetic network required for b-glucan
masking. Further, due to similarity in cell wall structure
between these two fungi, the genes we identiﬁed in
Saccharomyces could guide us to functionally equivalent genes
in Candida that serve the same masking function.
Using automated microscopy, we systematically screened
the entire library of approximately 4,800 S. cerevisiae mutants
for strains with increased b-glucan exposure. This platform
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Synopsis
Opportunistic fungal pathogens such as Candida albicans often
cause fatal infections in patients with a compromised immune
system. Unfortunately, current drugs often fail to halt fungal disease,
are ineffective against drug-resistant strains, and have severe side
effects. Despite the clear clinical significance of fungal infections, it is
still not understood how fungi are recognized by the immune
system. Candida has high levels of the structural molecule b-glucan
in its cell wall, but the majority of its b-glucan is masked by a
mannoprotein coat and is therefore invisible to the immune system.
Masking of b-glucan may be a fungal virulence factor, because
exposed b-glucan provokes a proinflammatory response that is
important for mounting an effective immune response against the
fungus and clearing the infection. By surveying the genome of the
model fungus Saccharomyces cerevisiae (bakers’ yeast), the authors
discovered a genetic network required for masking b-glucan from
the immune system. Mutation of genes in this network in C. albicans
caused unmasking of b-glucan and an increased immune response
to the fungus. The authors also found that sublethal doses of the
antifungal drug caspofungin cause unmasking and lead to a greater
immune response. Drugs targeting this fungally conserved masking
network may provide new tools to fight fungal infections.Figure 1. Fungal b-Glucan Is Buried in the Cell Wall and Largely Inaccessible
(A) Transmission electron micrograph demonstrating layer structure of fungal cell wall (courtesy of C. Rondeau). The plasma membrane is tightly
connected to a thick layer of b-glucan network. Mannoproteins are linked to b-glucan and protrude outside of this layer to make up a dense coat.
Schematic adapted from [5].
(B–D) There is little b-glucan on live C. albicans or S. cerevisiae that is exposed and accessible to the anti-b-glucan antibody (B), the Dectin-CRD (C), or the
Dectin-CRD-anti-Myc probe (D). The staining with anti-b-glucan and Dectin-CRD-anti-Myc is nearly indistinguishable, and is more specific than that with
the directly labeled Dectin-CRD. The Dectin-CRD-anti-Myc has the same size as an antibody and the same specificity as Dectin-1. The difference in
staining between the b-glucan-binding reagents (B and D versus C) is likely due to the size of the reagents (IgG has dimensions of approximately 95
A ˚ 3171 A ˚ [33], while the CRD of CD69, which is similar to the Dectin-1 CRD, has dimensions of 44 A ˚ 332 A ˚ 330 A ˚ [34]) relative to the estimated pore
size of the S. cerevisiae cell wall (58 A ˚ [23]), and thus the monomeric Dectin-CRD likely has more access to smaller areas of exposed b-glucan.
DOI: 10.1371/journal.ppat.0020035.g001
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Fungal Masking Alters Immune Responsepermits quantiﬁcation of the ﬂuorescence from high reso-
lution pictures of the b-glucan- stained yeast. This method of
quantiﬁcation is exempliﬁed in the comparison of the vrp1D
mutant to wild-type (Figure 3A). Strains with levels of
antibody binding greater than two standard deviations from
the mean of each plate were identiﬁed, and independently
created mutants were rescreened using the same protocol (see
Materials and Methods).
Emphasizing the connection between b-glucan exposure
and immune recognition, most of the mutants with greater
exposed b-glucan also showed increased binding to the
Dectin-1 b-glucan receptor (Figure 3B). The greater exposure
of b-glucan and better binding to Dectin-CRD of these
mutants raised the possibility that they would have altered
interaction with cells of the immune system. Each S. cerevisiae
mutant was exposed to RAW264.7 murine macrophages and
tested for TNFa elicitation. A large percentage (48 of 76) of
the unmasked mutants triggered a signiﬁcantly stronger
proinﬂammatory response than did the wild-type lab strain
of S. cerevisiae; some elicited up to ten times the amount of
TNFa as did wild-type (Figure 3B and Table S1). Taking gas1D
as a representative mutant with an intermediate phenotype,
we found increased binding of the anti-b-glucan antibody to
this mutant, and this binding is blocked by soluble b-glucan
(Figure 3C). The gas1D mutant also binds Dectin-CRD better
and elicits a higher level of TNFa from macrophages (Figure
3D and 3E). The strong correlation between b-glucan
exposure and increased TNFa elicitation suggests that b-
glucan masking on the surface of Saccharomyces is a key factor
in blocking the immune response to fungi.
Most of the genes identiﬁed in our screen for the masking
of b-glucan from the immune system ﬁt under an umbrella of
interconnected gene networks that regulate polarized cell
wall remodeling (Figure 4): polarization of the actin cytoske-
leton, polarized secretion of proteins and polysaccharides,
and polarized endocytosis of unwanted byproducts [13,14].
The connections among these related pathways imply that
coordination of polarized cell wall remodeling at sites of new
cell wall addition is crucial for masking b-glucan. This
interconnected network is sensitive to caspofungin. Three
of the key hubs of the network (SLT2, SLA1, and MNN10) are
required for caspofungin resistance [15,16]. Furthermore, the
Slt2p mitogen-activated protein kinase is a key mediator of
the caspofungin-induced stress response [16].
In addition, several genes required for mannosylation of
cell wall proteins (MNN10, MNN11, OCH1, OST3, and OST4)
are also required for masking of b-glucan and immune
recognition. The connection between mannoprotein process-
ing and b-glucan masking buttresses the idea that a dense
coat of mannosylated cell wall proteins masks b-glucan from
recognition. Apparently the increase in exposure is due to
uncoating or disorganization of the cell wall rather than bulk
changes in b-glucan levels, because in those hypereliciting
mutants for which the bulk level of b-glucan is known, the
vast majority of mutants (14 of 18) has unchanged or lower
levels of both types of b-glucan (Table 1).
As well as ﬁnding genes known to play a role in cell wall
architecture (Figure S2), our screen identiﬁed many new
genes that likely play roles in cell wall function (Figure 4). We
identiﬁed four genes that encode global transcriptional
regulatory proteins (ASF1, IES6, MOT2, and SSN8) and six
genes with previously unassigned biological function (DIA2,
VAC14, RDS2, YMR315W, YNL045W, and YPL158C) that were
not expected a priori to be required for masking b-glucan or
for recognition by the immune system. The stringency of our
screen clearly implicates each of these genes in the cell wall
remodeling process.
Several of the mutants with increased binding to anti-b-
Table 1. b-Glucan Exposure Does Not Correlate with Bulk Level in S. cerevisiae Mutants
ORF Number Gene Name Gene Description b1,6-Glucan Level
a b1,3-Glucan Level
a
YJL062W LAS21 Involved in the attachment of GPI anchors to proteins.   
YPR159W KRE6 ER b1,6 synthase    (þþ)
YLR242C ARV1 Sterol uptake into membrane, sphingolipid metabolism ( )(  )
YDR245W MNN10 Mannosylation þ   
YLR337C VRP1 Involved in cytoskeletal organization and cellular growth þþþ þþ
YNL084C END3 Required for endocytosis and organization of the cytoskeleton þþþ þþ
YBR171W SEC66 Secretion WT  
YAL016W TPD3 Protein phosphatase 2A regulatory subunit A WT WT
YBR200W BEM1 SH3-domain protein that plays a role in cellular polarization WT WT
YDR129C SAC6 Fimbrin homolog (actin-filament bundling protein) WT WT
YER068W MOT2 Part of CCR4-NOT histone acetylation complex WT WT
YKL048C ELM1 Serine/threonine kinase that regulates pseudohyphal growth WT WT
YLR370C ARC18 Part of arp2/3 complex WT WT
YOR085W OST3 Mannosylation WT WT
YKL048C ACE2 G1-phase transcription factor WT WT
YCR034W FEN1 Involved in synthesis of 1,3-b-glucan ND Lower
b
YGL038C OCH1 Mannosylation ND WT
c
YMR307W GAS1 Glycophospholipid-anchored surface protein WT
d Lower
d
aUnless otherwise noted, all measurements are published in [36]: Increase (I):þþþ, I . 100%;þþ,6 5, I , 100;þ,4 5, I , 65; (þ), 25 , I , 45; (þþ), I , 25%. Decrease (D):   ,8 5, D ,
100;    ,6 5, D , 85;  ,4 5, D , 65; ( ), 25 , D , 45; (   ), D , 25%.
bSee [37].
cSee [38].
dSee [39].
ND, no data; WT, wild-type.
DOI: 10.1371/journal.ppat.0020035.t001
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Fungal Masking Alters Immune Responseglucan antibody did not hyperelicit TNFa from macrophages.
This could be due to different epitope speciﬁcity between
antibody and the full-length receptor on the macrophage. To
address this issue, we probed all of the ‘‘unmasked’’ mutants
with a Dectin-CRD-anti-Myc probe (CRD-Myc) that colocal-
izes with Dectin-CRD and Dectin-1 (see Figure 1A). This CRD-
Myc probe should have a similar size to anti-b-glucan and the
same binding speciﬁcity as the Dectin-1 receptor. Only three
of the 28 non-hyperelicitors showed even marginally in-
creased binding to both Dectin-CRD and CRD-Myc (gup1D,
kre11D, and ylr111wD), suggesting that differences in epitope
recognition between the anti-b-glucan antibody and receptor
account for a majority of the mutants that have greater anti-b-
glucan binding but no hyperelicitation (Table S2).
Alternatively, different levels of mannoprotein could
independently alter immune response and confound these
results. To examine the surface mannoprotein structure, we
quantiﬁed the level of exposed mannose on the surface of live
yeast by incubating with the mannose-speciﬁc lectin con-
canavalin A (ConA). Although two mutants with known roles
in mannosylation (i.e., van1D, mnn2D) showed reduced bind-
ing to ConA, we did not ﬁnd a preponderance of mutants
with reduced binding among our set of exposed mutants and,
importantly, did not see any correlation between ConA
binding and TNFa elicitation (Table S2). Therefore, under
these conditions, overall levels of mannan on the surface do
not appear to regulate TNFa elicitation independently of b-
glucan recognition.
The Genetic Pathway for b-Glucan Masking Is Conserved
in C. albicans
The screen in S. cerevisiae identiﬁed potential genes and
pathways regulating b-glucan masking in pathogenic fungi,
and suggested that their C. albicans homologs might have a
similar masking function in this pathogen. Mutations in two
of these homologs (PHR2 and KRE5) resulted in attenuated
virulence in mice, and we reasoned that exposure of b-glucan
may contribute to their reduced virulence. We found that
mutations in each of three different b-glucan masking genes
caused increased b-glucan exposure in C. albicans (Figure 5).
The PHR2 gene is the only C. albicans homolog of the S.
cerevisiae GAS1 gene active under our growth conditions. It
encodes a b-glucan transglycosylase required for b-glucan
branching, cell wall integrity, and cell wall maintenance
[17,18]. When grown in our conditions, the phr2D/D mutant
displays a strong increase in the exposure of b-glucan (Figure
5A and 5D).
The homozygous kre5D/D mutant of C. albicans also showed a
dramatic increase in b-glucan exposure (Figure 5B and 5E).
We examined its function in C. albicans because it is
nonessential in this fungus yet has a similar function to
KRE6, which was identiﬁed in the S. cerevisiae screen (the S.
cerevisiae kre5D mutant is lethal and therefore is not in the
deletion library). Both KRE5 and KRE6 play important roles
in the synthesis of b1,6-glucan, which is a minor component
of the cell wall by weight but is important for cell wall
organization and for anchoring of mannoproteins in the wall
[19]. In C. albicans, homozygous kre5D/D mutants are avirulent
in the mouse model of infection and have defects in
ﬁlamentous growth and adherence to epithelial cells [20].
C. albicans has a single homolog of the S. cerevisiae gene,
which encodes a global transcriptional regulator. The
homozygous ssn8D/D mutant displays a mild increase in b-
glucan exposure that is reproducibly found constrained to
the tips of cells and ﬁlaments (Figure 5C and 5F). This
polarized exposure of b-glucan is identical to that found in
the phenotype of the S. cerevisiae ssn8D mutant, which is also
altered in ﬁlamentation. The increased exposure of b-glucan
at the tips and junctions, which are sites of cell wall
remodeling, suggests that in wild-type growth there must be
genes such as SSN8 that direct the reconstitution of the wall.
The homozygous C. albicans ssn8D/D mutant is mildly
ﬁlamentous even in rich (yeast peptone dextrose [YPD])
media, which normally promotes yeast-form growth, showing
that ﬁlamentation and b-glucan masking appear to be
separable phenomena.
Unmasked C. albicans Mutants Elicit More
Proinflammatory Cytokines through the b-Glucan
Receptor
To test whether increased exposure of Candida b-glucan in
these mutants also leads to altered immune recognition, we
exposed wild-type or mutant Candida to RAW 264.7 macro-
phages and examined the elicitation of TNFa. As shown in
Figure 6A, the Candida mutants with increased b-glucan
exposure elicited higher levels of TNFa from macrophages.
The relationship between b-glucan exposure and increased
proinﬂammatory response is biologically relevant because
unmasked mutants of S. cerevisiae (Figure S3) and C. albicans
(Figure 6B) also elicited higher levels of TNFa and interleukin
6( I L - 6 )( F i g u r eS 4 )f r o mB M D M s .T h i sd i f f e r e n c ei n
elicitation is not simply a dosage effect, because this
phenomenon occurs at different ratios of fungi to macro-
phages (Figure 6B). The altered signaling is also dependent on
the b-glucan receptor, because the great majority of the
increased elicitation of proinﬂammatory cytokines could be
blocked by preincubation of the macrophages with the
soluble b-glucan laminarin (Figure 6C). These data suggest
that the majority (if not all) of the increased elicitation of
proinﬂammatory cytokines occurs through the b-glucan
receptor.
Discussion
We found that ‘‘unmasking’’ the inner b-glucan layer of
fungi causes their altered recognition by innate immune cells.
Figure 2. Subinhibitory Concentrations of the Antifungal Drug CF Cause Exposure of b-Glucan
Wild-type C. albicans (CAF2) was grown overnight for ten generations in YPD medium, favoring yeast-form growth (A, B, C, and E) or RPMI medium,
favoring hyphal growth (D). Cultures grown at one-quarter and one-eighth of the CF MIC50 were stained with anti-b-glucan antibody and Cy3-labeled
secondary antibody (A and D) for visualization by microscopy or with PE-labeled secondary antibody (B) for FACS quantification. Mean fluorescence
intensity (MFI) values were 9, 65, and 161, respectively, for no treatment, one-eighth the CF MIC50, and one-quarter the CF MIC50. Concurrently, cells
were labeled briefly with propidium iodide to assess viability and visualized by epifluorescence microscopy or quantified by FACS (C). Cells grown
overnight in YPD with or without CF were UV-inactivated and then exposed to BMDMs at a yeast:macrophage ratio of 10:1. Supernatants were taken at
6 h and assayed for TNFa (E).
DOI: 10.1371/journal.ppat.0020035.g002
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Fungal Masking Alters Immune ResponseUsing the genome knockout library of S. cerevisiae as a guide,
we identiﬁed the set of genes that establish and maintain the
cell wall architecture in such a way that the majority of b-
glucan is not recognized. The mutants identiﬁed in this
screen are recognized better than the wild-type by the
Dectin-1 b-glucan receptor, and they hyperelicit the proin-
ﬂammatory cytokine TNFa from macrophages. Furthermore,
mutation of cognate genes in the pathogen C. albicans leads to
unmasking of b-glucan and hyperelicitation of proinﬂamma-
tory cytokines in primary macrophages in a b-glucan-
dependent manner. We also found that caspofungin unmasks
fungal b-glucan at subinhibitory concentrations of the drug
and alters recognition of C. albicans. This unanticipated
activity may assist in fungal clearance during treatment of
an infection.
The fungal mutants with exposed b-glucan and increased
binding to Dectin-1 stimulate increased levels of proinﬂam-
matory cytokines independent of their bulk level of b-glucan.
By creating barriers on their surfaces, fungal pathogens may
mask certain PAMPs from the immune system and subvert
the immune response. The immune system may also be able
to counteract this fungal defense by unmasking the signature
components of the fungus during the course of infection. For
example, soluble or phagosomal proteases could remove the
mannoprotein coat, which is known to expose b-glucan [21].
Differential exposure and unmasking could in part explain
the diverse potential of fungi for pathogenesis.
Figure 3. Automated Genome-Wide Screen for Increased b-Glucan Exposure
We screened the genome-wide set of S. cerevisiae knockout mutants by staining with anti-b-glucan antibody and quantifying b-glucan exposure using
the Cellomics system.
(A) Images of yeast were taken at 203, and object-finding software used the ConA fluorescence signal to identify cells (green outline); the software then
applied a mask (blue outline) and quantified the average level of fluorescence from the anti-b-glucan channel for each cell. Wild-type yeast (left
photomicrographs) show little or no fluorescence from the anti-b-glucan channel, whereas the unmasked vrp1D mutant shows high levels of
fluorescence from this channel.
(B) Most of the mutants found with increased b-glucan exposure also showed greater binding to Dectin-CRD and increased TNFa elicitation from RAW
264.7 macrophages. Of the 76 mutants identified with increased anti-b-glucan binding (encircled with the black line), 48 (encircled with the dotted line)
hyperelicited TNFa from macrophages and 65 (encircled with the red line) showed increased binding to the labeled Dectin-CRD. Numbers within the
black oval show the intersections of each of these groups (e.g., 44 had increased anti-b-glucan binding and increased Dectin-CRD binding and increased
TNFa elicitation from macrophages).
(C–E) To exemplify the methodology used, we chose the gas1D mutant, which has intermediate b-glucan exposure and TNFa elicitation. (C) Live wild-
type (upper left image) or gas1D mutant (lower left image) S. cerevisiae were stained with anti-b-glucan antibody. To show specificity of the binding,
gas1D cells were stained omitting primary antibody (upper right image) or antibody was preincubated in 100 lg/ml soluble glucan (laminarin) before
and during the staining (lower right image). (D) Live wild-type or gas1D mutant cells were stained with Alexa Fluor-labeled Dectin-CRD. (E) Live wild-
type or gas1D mutant cells were exposed to RAW264.7 macrophages at a ratio of 5:1 (yeast:macrophage), and supernatants were collected after 6 h and
measured for TNFa levels.
DOI: 10.1371/journal.ppat.0020035.g003
Figure 4. The Cell Wall Remodeling Network Required for b-Glucan Masking
A map of physical and genetic interactions among b-glucan masking genes was made using the Osprey v1.2.0 visualization program (available at:
http://biodata.mshri.on.ca/osprey/servlet/Index). All genes of hypereliciting mutants identified in the screen are represented. Lines connecting genes
are colored to represent the nature of known interaction(s) between a pair of genes (i.e., synthetic lethality, two-hybrid, or coimmunoprecipitation).
Vertices are colored to represent the cellular processes directed by the gene product, as annotated by the Yeast Proteome Database (available at http://
www.proteome.com). Vertices of genes required for caspofungin resistance [15,16] are circled in black.
DOI: 10.1371/journal.ppat.0020035.g004
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Fungal Masking Alters Immune ResponseFigure 5. C. albicans Mutants of Masking Genes Have More Exposed b-Glucan
Wild-type or mutant C. albicans strains were grown overnight in YPD, then stained with anti-b-glucan antibody and Cy3-labeled (A–C) or PE-labeled (D–
F) secondary antibody.
(A–C) Upper photomicrographs show overlay of brightfield and anti-b-glucan staining of Cy3-labeled cells; lower photomicrographs show anti-b-glucan
staining alone.
(D–F) Overlay histograms of FACS analysis of PE-labeled cells; data on 20,000 cells are shown. MFI values for wild-type and mutants are shown in insets.
In parallel experiments, strains that were complemented with a wild-type copy of the gene showed full reversal of b-glucan exposure (for KRE5)o r
partial reduction in exposure (for PHR2) (Figure S5). This correlates with other phenotypes observed for these complemented strains [17,20,35].
DOI: 10.1371/journal.ppat.0020035.g005
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Fungal Masking Alters Immune ResponseThe architecture of the fungal cell wall must be taken into
account when assessing how fungi are detected by immune
cells. The relative accessibility of b-glucan versus mannan on
the surface could favor quite different responses from
immune cells [22]. In this light, the ﬁnding that heat
inactivation alters the cell wall to expose b-glucan suggests
that experiments using heat-killed fungi or zymosan may
beneﬁt from complementary studies using live and/or UV-
inactivated fungi.
The exposure of b-glucan on the cell surface might be
altered by environmental conditions that affect the regula-
tion of the genes we have shown to affect cell wall
architecture. This effect could explain the reported greater
binding of Dectin-1 to the yeast form of C. albicans as
compared with its hyphal form [11]. In those experiments the
fungus was grown on one medium to foster growth of the
yeast form, and a different medium to induce the hyphal
form. The different media could affect b-glucan masking
independently of fungal morphotype [23]. Consistent with
this view, preliminary results with C. albicans mutants locked
in the yeast form suggest that simply modifying the media is
sufﬁcient to change the level of b-glucan masking (unpub-
lished data). As all of our comparisons were done with strains
grown on the same medium, the unmasking we observed
cannot be explained by alterations in environmental con-
ditions. Although yeast and hyphal forms showed no
fundamental differences with respect to b-glucan accessibility
and CF-induced unmasking, the morphotypes have other cell
wall differences that result in differential immune recogni-
tion [22,24].
The weak proinﬂammatory response elicited by wild-type
cells of C. albicans may prevent recruitment of effector cells
and clearance of the fungus, and explain its persistence
commensally in the gut in a large percentage of the
population [25]. Both TNFa and IL-6 have been shown to
be protective in the mouse model of disseminated candidia-
sis, suggesting that unmasking b-glucan could provoke a
proinﬂammatory response and attenuate virulence in dis-
seminated disease [26]. It is noteworthy that two of the
unmasked C. albicans mutants (phr2D/D and kre5D/D) are
avirulent [17,20], and it is possible that b-glucan unmasking
contributes to their attenuated virulence. However, these
mutations result in additional phenotypes [17,20] that cannot
be excluded as a cause of their virulence defects. Evaluating
the relevance of b-glucan masking to the immune response
will require further experiments in an informative whole-
animal model.
The ﬁnding that b-glucan unmasking by CF promotes the
proinﬂammatory response suggests that antimycotics such as
CF may strike at fungi in a dual way, killing them at high
concentrations and unmasking their b-glucan at lower
concentrations. In addition to enhancing nonopsonic, b-
glucan-mediated uptake and signaling, drug-induced expo-
sure of b-glucan may also target fungi for recognition by
natural anti-b-glucan antibodies, which have been charac-
terized in mouse and human sera [27]. Many other fungal
pathogens are sensitive to CF, have homologs of b-glucan-
masking genes, and can be sensed by Dectin-1 and/or targeted
via their b-glucan [6,8,28,29]. The proteins encoded by these
b-glucan-masking genes may provide useful drug targets for
broad-spectrum treatment of fungal infection.
Materials and Methods
Fungal strains and growth. S. cerevisiae strains in the BY4741 or
BY4742 background were used to make the complete deletion library
[30]. S. cerevisiae knockout libraries were purchased from Open
Biosystems (Huntsville, Alabama, United States). C. albicans strains
Figure 6. Unmasked C. albicans Mutants Hyperelicit TNFa from
Macrophages through the b-Glucan Receptor
(A) C. albicans strains were exposed to RAW264.7 macrophages at a ratio
of 2:1 (yeast:macrophage), and supernatants were collected after 6 h.
(B) Different numbers of C. albicans (wild-type or kre5D/D mutant) were
exposed to BMDMs, and supernatants were collected after 6 h.
(C) BMDMs were pretreated for 20 min on ice with media or soluble b-
glucan (laminarin); they were then exposed to different C. albicans strains
at a ratio of 10:1 (yeast:macrophage). After unbound fungi were washed
off, macrophages were incubated for 6 h at 37 8C, and supernatants were
collected for TNFa quantitation.
DOI: 10.1371/journal.ppat.0020035.g006
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Fungal Masking Alters Immune Responsewere derived from clinical isolate SC5314 [31]. Strain details are
shown in Table S3. Fungi were grown overnight in YPD rich medium
for yeast-form growth and RPMI 1640 for hyphal growth. C. albicans
was grown at 37 8C; S. cerevisiae was grown at 30 8C. For CF treatment,
overnight cultures of C. albicans CAF2 were diluted 1:1,000 into fresh
YPD or RPMI 1640 containing dilutions of CF (caspofungin acetate,
Cancidas formulation, Merck, Whitehouse Station, New Jersey,
United States) and grown overnight. MIC50 was 2.5 ng/ml. For
viability, cells were stained with propidium iodide (Sigma, St. Louis,
Missouri, United States).
Inactivation of fungi for macrophage interaction experiments. For
UV inactivation, the equivalent of 2.5310
7 cells from a culture were
washed and resuspended in 1 ml of PBS in a six-well plate. The fungi
were exposed to four doses of 100,000 ljoules/cm
2 in a CL-1000 UV-
crosslinker (UVP, Upland, California, United States), with agitation
between each dose to treat cells evenly. For heat inactivation, 2.5 3
10
7 cells in 1 ml of PBS were boiled for 10 min. After UV- or heat
inactivation, cells were washed and renormalized by OD600.I nS.
cerevisiae, we found greater b-glucan exposure on cells that were heat-
treated at 65 8C for 15 min, ﬁxed for 30 min on ice in 3.7%
formaldehyde, or ﬁxed for 30 min on ice in 70% ethanol
(unpublished data).
Screen for b-glucan exposure. Overnight cultures of strains were
grown in YPD and stained with anti-b-glucan primary antibody
(Biosupplies Inc., Parkville, Australia) and Cy3-labeled goat-anti-
mouse secondary. This antibody is speciﬁc for b1,3-glucan [10], and
costaining with this antibody and the puriﬁed Dectin-CRD shows
colocalization (unpublished data). Stained cells were adhered to
clear-bottom plates with concanavalin A (Sigma) and scanned with
Cellomics VTI ﬂuorescence microscopic imager (Cellomics, Pitts-
burgh, Pennsylvania, United States) using Target Acquisition software
(Zeiss, Oberkochen, Germany). Mean average intensity and standard
deviation of average intensity measurements were used to identify
strains with over two standard deviations greater b-glucan exposure.
Initially matA mutant strains were screened, then the independently
constructed mata counterparts were screened. Dectin-CRD was
expressed from pTrcHis2 vector (Invitrogen, Carlsbad, California,
United States), puriﬁed from E. coli as described [11], and labeled
directly with Alexa Fluor 555-succinimidyl ester (Molecular Probes,
Eugene, Oregon, United States). Fungi were labeled with pure protein
and showed glucan-inhibitable binding and similar staining pattern
to that described [11].
Macrophages. RAW264.7 macrophages (ATCC, Manassas, Virginia,
United States) were cultured in RPMI-10 (RPMI 1640 with 10% heat-
inactivated fetal bovine serum and standard concentrations of
penicillin-streptomycin; GIBCO, San Diego, California, United
States). Cells were collected and plated in 24-well plates at 5 3 10
5
cells/well. BMDMs were differentiated as described [32]. Brieﬂy, bone
marrow from BL/6 mice was cultured in RPMI-10 with 15% L-cell
conditioned media and 25 ng/ml recombinant M-CSF (R&D Systems,
Minneapolis, Minnesota, United States). Cells were collected after 6 d
and plated in 24-well plates at 5 3 10
5 cells/well. Mice were cared for
in the WIBR animal facility under protocol # 0203–008–06.
Macrophage-yeast interaction. Fungi were grown overnight,washed
extensively to remove any shed proteins or polysaccharides, and
normalized by OD600 or hemacytometer (these two methods produced
equivalent results). For S. cerevisiae, live fungi were added to RAW264.7
macrophages at equivalent effector:target (E:T) ratio of 1:5 in 24-well
plates and incubated for 6 h, when supernatants were collected for
ELISA. For exposure of C. albicans, UV-inactivated fungi were exposed
either to RAW264.7 macrophages at an equivalent E:T of 1:2 or to
BMDMs at an E:T of 1:10. For RAW264.7 exposures,supernatants were
collected after 2 h; for BMDM exposures, supernatants were collected
after 6 h. For blocking, BMDMs were preincubated with 100 lg/ml
laminarin for 20 min on ice, exposed to fungi for 30 min at 37 8C,
washed extensively, then incubated for 6 h more at 37 8C. ELISAs were
performed according to the manufacturer’s instructions (R&D
Systems). Note that soluble b-glucan (laminarin) alone does not
stimulate the macrophages (Figure 6C).
Staining, microscopy, and FACS. Fungi were grown overnight,
washed, blocked in PBSþ2% BSA, and stained with either the anti-b-
glucan antibody (followed by Cy3- or PE-labeled secondary antibody),
Alexa Fluor-labeled Dectin-CRD, or Dectin-CRD-anti-Myc. Staining
with antibody and Dectin-CRD is described above for the screen. For
staining with Dectin-CRD-anti-Myc, Dectin-CRD was preincubated
with FITC-labeled anti-Myc (Invitrogen) at a ratio of 3.4 lg of Dectin-
CRD þ 10 ll of anti-Myc, and then added to fungi at 1:100 on ice.
Preincubation of Dectin-CRD with anti-Myc creates a probe with the
same approximate size as the anti-b-glucan antibody but with the
speciﬁcity of Dectin-1. Images of stained cells were taken using a
Nikon TE2000-S microscope (Nikon, Tokyo, Japan) equipped with
Spot RT camera (Diagnostic Instruments, Sterling Heights, Michigan,
United States) and processed in Photoshop (Adobe Systems, Palo
Alto, California, United States). Fluorescence was quantiﬁed on a
FACScalibur cytometer (Becton-Dickinson, Palo Alto, California,
United States); cells were gated by forward and side scatter based on
wild-type cell size and shape, and mean ﬂuorescence intensity of
20,000 labeled cells was calculated using Cellquest software (Becton-
Dickinson).
Supporting Information
Figure S1. Heat Inactivation of C. albicans Causes Greater b-Glucan
Exposure and Greater Elicitation of TNFa
Wild-type (CAF2) fungi were grown overnight in YPD medium at 37
8C. Cells were killed by UV irradiation or by heat inactivation (10 min
at 100 8C).
(A) Live or killed cells were probed with anti-b-glucan antibody and
PE-labeled secondary antibody and with Alexa Fluor 488-labeled
Dectin-CRD, then subjected to FACS analysis.
(B) UV- or heat-killed cells were then exposed to BMDMs at a ratio of
10:1 (yeast:macrophage), and supernatants were taken after 6 h for
measurement of TNFa levels.
Found at DOI: 10.1371/journal.ppat.0020035.sg001 (271 KB PDF).
Figure S2. Overlap of b-Glucan Cell Wall Architecture Screen with
Other Cell Wall-Related Screens
We examined the intersection (A) between the genes required for b-
glucan masking (shown in green) and those identiﬁed by any one of
four other genome-wide cell wall-directed screens (shown in dark
red). These included (B) a screen to ﬁnd mutants with synthetic
lethality with genes required for b1,3-glucan biosynthesis (shown in
dark blue [1]), (C) a screen for mutants with altered sensitivity to
caspofungin (shown in light blue [1]), (D) two screens for mutants with
altered sensitivity to the chitin-binding drug calcoﬂuor white (shown
in orange [2]), and (E) a screen for mutants with altered sensitivity to
the cell wall-directed K1 killer toxin (shown in purple [3]).
Found at DOI: 10.1371/journal.ppat.0020035.sg002 (489 KB PDF).
Figure S3. The Unmasked S. cerevisiae gas1D Mutant Hyperelicits TNFa
from Primary Macrophages
BMDMs were exposed to different S. cerevisiae strains at a ratio of 5:1
(yeast:macrophage). After fungi were added, macrophages were
incubated for 6 h at 37 8C, and supernatants were collected for
TNFa quantitation.
Found at DOI: 10.1371/journal.ppat.0020035.sg003 (505 KB PDF).
Figure S4. Unmasked C. albicans Mutants Hyperelicit IL-6 from
Macrophages through the b-Glucan Receptor
BMDMs were pretreated for 20 min on ice with medium or soluble b-
glucan (laminarin), and were then exposed to different C. albicans
strains at a ratio of 10:1 (yeast:macrophage). After unbound fungi
were washed off, macrophages were incubated for 6 h at 37 8C, and
supernatants were collected for IL-6 quantitation.
Found at DOI: 10.1371/journal.ppat.0020035.sg004 (527 KB PDF).
Figure S5. Complementation of C. albicans Mutations Partially or Fully
Reverses b-Glucan Exposure Phenotype
Wild-type or mutant C. albicans strains were grown overnight in YPD,
then stained with anti-b-glucan antibody and PE-labeled secondary
antibody. Overlay histograms of FACS analysis of PE-labeled cells;
data on 20,000 cells is shown. MFI values for wild-type and mutants
are shown in insets. The partial reduction in b-glucan exposure (for
PHR2) (A) or full reversal (for KRE5) (B) correlates with other
phenotypes observed for these complemented strains [1–3].
Found at DOI: 10.1371/journal.ppat.0020035.sg005 (582 KB PDF).
Table S1. Overall Phenotype of Hypereliciting Mutants
Found at DOI: 10.1371/journal.ppat.0020035.st001 (106 KB DOC).
Table S2. Characterization of Exposed Mutants That Do Not
Hyperelicit Cytokines
Found at DOI: 10.1371/journal.ppat.0020035.st002 (70 KB DOC).
Table S3. Fungal Strains
Found at DOI: 10.1371/journal.ppat.0020035.st003 (66 KB DOC).
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